COMBAT DRUGS Fact Sheet, COMBAT DRUGS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COMBAT DRUGS Fact Sheet    (CMDG)


EV Stocks: Which is Tanushree's Top Pick?


Here is the latest financial fact sheet of COMBAT DRUGS. For more details, see the COMBAT DRUGS quarterly results and COMBAT DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

COMBAT DRUGS Price History

Price Rs 65.9
Mkt Cap Rs m 666
Vol '000 43.1
P/E X 21.7
P/CF X 30.0
EPS (TTM) Rs 3.0
% ch % 9.9
No. of shares m 10.10
% ch week % 43.6
% ch 1-mth % 120.8
% ch 12-mth % 159.4
52 week H/L Rs 65.9/24.6
(As on Dec 3, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

COMBAT DRUGS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
COMBAT DRUGS EQUITY SHARE DATA
High Rs1227313441 
Low Rs37171618 
Sales per share (Unadj.) Rs0.51.310.123.755.0 
Earnings per share (Unadj.) Rs-0.20.20.51.11.4 
Diluted earnings per shareRs-0.20.20.41.11.4 
Cash flow per share (Unadj.) Rs-0.20.20.51.62.2 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs2.42.73.212.413.6 
Adj. book value per shareRs1.92.12.512.413.6 
Shares outstanding (eoy) m8.008.008.0010.1010.10 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x16.213.72.41.10.5 
Avg P/E ratio x-33.076.447.923.121.3 
P/CF ratio (eoy) x-33.076.447.815.313.4 
Price / Book Value ratio x3.16.67.72.02.2 
Dividend payout %00000 
Avg Mkt Cap Rs m61139194254298 
No. of employees `000NANANANANA 
Total wages/salary Rs m1210193473 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
COMBAT DRUGS INCOME DATA
Net Sales Rs m41081240556 
Other income Rs m01036 
Total revenues Rs m41181243562 
Gross profit Rs m-2142535 
Depreciation Rs m00068 
Interest Rs m000812 
Profit before tax Rs m-2241521 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00047 
Profit after tax Rs m-2241114 
Gross profit margin %-49.26.85.610.56.3 
Effective tax rate %008.024.934.5 
Net profit margin %-49.218.05.04.62.5 
COMBAT DRUGS BALANCE SHEET DATA
Current assets Rs m43063227225 
Current liabilities Rs m6838213173 
Net working cap to sales %-62.3208.431.05.69.4 
Current ratio x0.63.51.71.11.3 
Inventory Days Days2,1601111777 
Debtors Days Days1322111,5662,224766 
Net fixed assets Rs m2200127161 
Share capital Rs m808080101101 
"Free" reserves Rs m-61-59-552536 
Net worth Rs m192125126137 
Long term debt Rs m000067 
Total assets Rs m263063353387 
Interest coverage xNMNM74.52.92.8 
Debt to equity ratio x00000.5 
Sales to assets ratio x0.10.31.30.71.4 
Return on assets %-7.26.26.55.36.7 
Return on equity %-9.58.616.08.810.2 
Return on capital %-9.38.617.717.816.2 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
COMBAT DRUGS CASH FLOW
From Operations Rs m 0 -1 2 -152 18 
From Investments Rs m 0 0 0 -1 -3 
From Financial Activity Rs m 0 1 1 164 40 
Net Cashflow Rs m 0 0 3 12 55 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 45.9%
Institution 0.0%
Non-Institution 54.1%
Total 100.0%
Free Float 54.1%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Plot No. 94 4th Floor, Road No. 2 Sagar Society, Banjara Hills, Hyderabad - 500034
E-MAIL info@decipherlabs.in WEB www.dechipherlabs.in
TEL 040-48536100 FAX
SECTOR PHARMACEUTICALS GROUP MNC
TR AGENT Venture Capital & Corporate Investments Ltd, 12-10-167, MIG- 167, Bharat Nagar Colony
YEAR OF INC: 1986 BSE CODE: 524752 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SUN PHARMA  

Compare COMBAT DRUGS With:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SUN PHARMA  




Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Views on news

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK COMBAT DRUGS

  • Track your investment in COMBAT DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON COMBAT DRUGS

COMBAT DRUGS 8-QTR ANALYSIS

COMPARE COMBAT DRUGS WITH

MARKET STATS